PACIRA PHARMACEUTICALS INC's ticker is and the CUSIP is 695127AB6.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $14,626,000 | -19.9% | 5,100,000 | 0.0% | 2.15% | -29.4% |
Q1 2015 | $18,260,000 | -0.3% | 5,100,000 | 0.0% | 3.04% | +18.1% |
Q4 2014 | $18,324,000 | -29.1% | 5,100,000 | -22.7% | 2.57% | -18.9% |
Q3 2014 | $25,842,000 | +4.4% | 6,600,000 | 0.0% | 3.17% | -12.9% |
Q2 2014 | $24,749,000 | – | 6,600,000 | – | 3.64% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nantahala Capital Management | 6,600,000 | $25,842,000 | 3.17% |
WHITEBOX ADVISORS LLC | 13,657,000 | $53,331,000 | 2.07% |
WOLVERINE ASSET MANAGEMENT LLC | 21,393,000 | $83,860,000 | 1.75% |
MACKAY SHIELDS LLC | 5,466,000 | $21,372,000 | 1.11% |
SSI INVESTMENT MANAGEMENT LLC | 767,000 | $3,000,000 | 0.29% |
Citadel Advisors | 29,628,000 | $115,835,000 | 0.12% |
Visium Asset Management, LP | 1,500,000 | $5,884,000 | 0.09% |
LAZARD ASSET MANAGEMENT LLC | 4,884,000 | $19,072,000 | 0.04% |
FRANKLIN RESOURCES INC | 5,880,000 | $22,991,000 | 0.01% |
Invesco Ltd. | 1,500,000 | $5,858,000 | 0.00% |